Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GALECTIN THERAPEUTICS INC.

(GALT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about GALECTIN THERAPEUTICS INC.
01/06Galectin Therapeutics to Present at the H.C. Wainwright BioConnect Conference
AQ
2021Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chair..
AQ
2021GALECTIN THERAPEUTICS : Announces Closing of $10 Million in Debt Financing from Its Chairm..
PU
2021Galectin Therapeutics Inc. announced that it has received $20 million in funding
CI
2021Galectin Therapeutics Discusses Corporate Transformation, Progress of NAVIGATE Trial an..
AQ
2021GALECTIN THERAPEUTICS : Thanks Kevin - Form 8-K
PU
2021GALECTIN THERAPEUTICS : Reports Financial Results for the Quarter Ended September 30, 2021..
PU
2021Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 202..
GL
2021Galectin Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
2021Galectin Therapeutics to Present Six Scientific Abstracts at The Liver Meeting 2021, Ho..
AQ
2021UPDATE – Galectin Therapeutics to Present Six Scientific Abstracts at The Liver M..
GL
2021UPDATE – Galectin Therapeutics to Present Six Scientific Abstracts at The Liver M..
GL
2021Galectin Pharmaceuticals to Present Six Scientific Abstracts at The Liver Meeting 2021,..
AQ
2021Galectin Pharmaceuticals to Present Six Scientific Abstracts at The Liver Meeting&trade..
AQ
2021GALECTIN THERAPEUTICS : to Participate in the H.C. Wainwright 5th Annual NASH Investor Con..
AQ
2021UPDATE : Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Inves..
GL
2021UPDATE : Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Inves..
GL
2021GALECTIN THERAPEUTICS : to Participate in the H.C. Wainwright 23rd Annual Global Investmen..
AQ
2021GALECTIN THERAPEUTICS : Secures $20 Million Debt Financing from Chairman Richard Uihlein
MT
2021GALECTIN THERAPEUTICS : Announces $20 Million Convertible Debt Financing from Its Chairman..
PU
2021GALECTIN THERAPEUTICS : Announces $20 Million Convertible Debt Financing from Its Chairman..
AQ
2021Galectin Therapeutics Inc. announced that it expects to receive $20 million in funding
CI
2021GALECTIN THERAPEUTICS : Presentation for H.C. Wainwright 23rd Annual Global Investment Con..
PU
2021Galectin Therapeutics, Inc. to Participate in the H.C. Wainwright 23rd Annual Global In..
GL
2021GALECTIN THERAPEUTICS : Strengthens Leadership Team with Strategic Hires to Advance Progra..
AQ
2021Galectin Therapeutics Inc. Announces Board Appointments
CI
2021GALECTIN THERAPEUTICS : Q2 Loss Widens, Sees Enough Funds Till September Next Year; Shares..
MT
2021GALECTIN THERAPEUTICS : Considering options for a Combination Cancer Immunotherapy trial b..
PU
2021Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2021, an..
GL
2021Galectin Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 3..
CI
2021NORTH AMERICAN MORNING BRIEFING : Weak Chinese -3-
DJ
2021GALECTIN THERAPEUTICS : Regulation FD Disclosure (Form 8-K)
PU
2021GALECTIN THERAPEUTICS : Announces Positive Top-Line Results from a Phase 1b Clinical Trial..
AQ
2021GALECTIN THERAPEUTICS : Reports Positive Data From Trial of Belapectin, Keytruda Combinati..
MT
2021GALECTIN THERAPEUTICS : Announces Positive Top-Line Results from a Phase 1b Clinical Trial..
AQ
2021Galectin Therapeutics Inc. Announces Positive Top-Line Results from A Phase 1B Clinical..
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 2500 Growth Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 3000E Growth Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 3000 Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 2000 Dynamic Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 3000E Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 2500 Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell Small Cap Completeness In..
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 2000 Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 3000 Growth Index
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell Small Cap Comp Growth Ind..
CI
2021GALECTIN THERAPEUTICS INC.(NASDAQCM : GALT) dropped from Russell 2000 Growth Index
CI
2021GALECTIN THERAPEUTICS : Reports Financial Results for the Quarter Ended March 31, 2021, an..
AQ
2021GALECTIN THERAPEUTICS : Reports Financial Results for the Quarter Ended March 31, 2021, an..
PU
2021Galectin Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 3..
CI
2021INSIDER TRENDS : Galectin Therapeutics Insider Sale Interrupting 90-Day Buy Trend
MT
2021Galectin Therapeutics to Present at 4th Global NASH Congress
GL
2021GALECTIN THERAPEUTICS : World-Renowned Neurosurgeon Dr. Ben Carson, Sr. Joins Galectin The..
AQ
2021GALECTIN THERAPEUTICS : Thinking about buying stock in Westport Fuel Systems, Galectin The..
PR
2021GALECTIN THERAPEUTICS : World-Renowned Neurosurgeon Dr. Ben Carson, Sr. Joins Galectin The..
AQ
2021Galectin Therapeutics Inc. Announces Executive Changes
CI
2021GALECTIN THERAPEUTICS : HC Wainwright Adjusts Price Target on Galectin Therapeutics to $14..
MT
2021Galectin Therapeutics Inc. announced that it has received $10 million in funding
CI
2021US Stocks End Mostly Lower as Top Banks Kickstart Earnings Season
MT
2021CLOSE UPDATE : US Stocks Ended Mostly Lower as Top US Banks Kickstart Earnings Season
MT
2021SECTOR UPDATE : Health Care Stocks Giving Back Most of Wednesday Gains
MT
2021Wall Street Off Early Highs Midday as Top Banks Start Earnings Season
MT
2021SECTOR UPDATE : Health Care Stocks Narrowly Mixed in Recent Trade
MT
2021MIDDAY REPORT : Wall Street Off Early Highs Midday As Top US Banks Start Earnings Season
MT
2021SECTOR UPDATE : Health Care Stocks Mixed Premarket Wednesday
MT
2021Wall Street Futures Tread Water as Earnings Season Kicks Off
MT
2021US Futures Flat as Earnings Season Kicks Off
MT
2021GALECTIN THERAPEUTICS : Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Res..
AQ
2021GALECTIN THERAPEUTICS : Says Belapectin Drug Combination Enhances Tumor Response
MT
2021Journal for ImmunoTherapy of Cancer Publishes Phase 1 Clinical Research Showing Belapec..
GL
2021Galectin Therapeutics Launches NAVIGATEnash.com, a Resource for Both Patients and Physi..
GL
2021Galectin Therapeutics Reports Fiscal 2020 Financial Results and Provides Business Updat..
GL
2021Galectin Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 3..
CI
2021GALECTIN THERAPEUTICS : Corporate Presentation MARCH 2021.pdf
PU
1  2  3  4  5Next
Upcoming event on GALECTIN THERAPEUTICS INC.
03/30/22